Medifile
Abstract
This Medifile issue reviews 3 topical subjects following recent publications. Firstly, the safety concerns on the long acting ß2-adrenergic agonists (LABAs) are discussed, following the recent safety warnings published by the FDA. Next, the outcomes of the Fosamax Actonel Comparison Trial (FACT), published in 2005, are reviewed with a focus on the practical application of the trial results in terms of reduction of fracture risk. Finally, we provide an overview of existing and current studies on the relationship between male circumcision and the possible reduction of HIV infection, following the publication of the results of the South African Male circumcision in HIV randomized controlled trial (the ANRS 1265 Trial).
Section
Regulars
By submitting manuscripts to SAFP, authors of original articles are assigning copyright to the South African Academy of Family Physicians. Copyright of review articles are assigned to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAFP for educational and research purposes without obtaining permission.
